Incheon's first Ion procedure draws international attention
Robot-assisted bronchoscopy reaches small peripheral lung nodules with precision
Early diagnostic yield tops 95%, confirmation rate exceeds 90%
Inha University Hospital has shared its expertise in robot-assisted lung cancer diagnosis with medical staff from one of Taiwan's leading national university hospital cancer centers.
The hospital's clinical experience and diagnostic results with a next-generation robotic bronchoscope have drawn attention from the international medical community, highlighting the competitiveness of Incheon's medical technology.
Pulmonology staff from the National Taiwan University Cancer Center recently visited Inha University Hospital to observe biopsy procedures using the Ion robotic bronchoscope system, the hospital announced Tuesday.
During the visit, the Taiwanese medical team watched Professor Kim Hye-su of the hospital's pulmonology department perform Ion procedures, studying how the device is operated, how biopsies are conducted and how the system approaches lung lesions.
That staff from an overseas cancer center traveled to a domestic hospital to observe procedures in person underscores the growing international recognition of Inha University Hospital's accumulated experience in robot-based lung cancer diagnosis.
What drew the Taiwanese team's interest was the Ion system's precision diagnostic capability, which overcomes the access limitations of conventional bronchoscopes.
Inha University Hospital introduced the Ion system in April, becoming the third institution in the Greater Seoul area and the first in Incheon to do so. Early clinical data gathered since then have confirmed the technology's performance.
In initial cases, the diagnostic yield for lung nodule biopsies reached 95%, with a confirmation rate exceeding 90%.
"It is highly significant that accurate diagnosis is leading to prompt treatment for patients," said Lim Jun-hyeok, chief of the pulmonology department at Inha University Hospital. "The fact that medical staff from an overseas cancer center visited in person to observe our procedures is a testament to the recognition our robotic bronchoscopy capabilities have earned."
gilbert@heraldcorp.com
